SHANGHAI – China's stock market collapse over the past week has been on everyone's minds. Eyes have been glued to cell phone apps with greater concentration than ever before, checking minute to minute how fast and how far share prices will fall. Read More
SHANGHAI – The Shanghai-based contract research organization/contract manufacturing powerhouse, Wuxi Apptec, is on the move again, this time demonstrating its ability to creatively leverage capital markets to fund expansionary plans. Read More
HONG KONG — An oral cholera vaccine has been shown to be safe and protective against severe disease in children and adults in urban Bangladesh where the disease is endemic, supporting its use in mass immunization programs, according to the first real-life trial of the new Shanchol vaccine. Read More
NEW DELHI – The WHO has rapped yet another Indian clinical research organization (CRO) for "critical lapses and major deviations" during the conduct of clinical trials, bringing the spotlight back to the need for Indian pharma firms and CROs to pull up their socks over stringent adherence to trial protocols. Read More
NEW DELHI – The Indian pharma industry is struggling with data integrity issues that repeatedly crop up during inspections by global regulators; they are tarnishing the industry's reputation while undermining global confidence in Indian products. Read More
Oramed Pharmaceuticals Inc., of Jerusalem, signed a nonbinding letter of intent for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science & Technology Park Investments and Development Co. Ltd. Read More
